is tirzepatide patented The Heavy Price of GLP-1 Drugs – I-MAK Half-truth. That's the honest answer

Also known as GLP-1 medications, these popular drugs were initially approved to treat type 2 diabetes, but doctors quickly discovered that they also facilitated significant weight loss thus, the birth of the weight-loss drug craze.

The 2.5 mg dosage is for treatment initiation and is not intended for glycemic control.After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly.If additional glycemic control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on thecurrent dose.The maximum dosage of MOUNJARO is 15 mg injected subcutaneously once weekly.If a dose is missed, instruct patients to administer MOUNJARO as soon as possible within 4 days (96 hours) after themissed dose

In a prespecified analysis of the SELECT trial, semaglutide demonstrated significant reductions in cardiovascular mortality and HF hospitalizations for patients with HF and ASCVD

Sickle Cell Anemia: A genetic disorder where red blood cells are misshapen (sickle-shaped), leading to blockages in blood flow and causing anemia

From GLP-1 to New Horizons: Pharma's Obesity Revolution